Recent Finacing
Recent Raise
Helico develops plant-based production of therapeutic compounds—starting with insulin—combining GMO plant cultivation, a proprietary computational synthetic-biology platform with AI models, and regulated R&D in certified Auckland labs.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
